These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1996588)

  • 1. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
    Weidler DJ; Vidt DG; Toth PD; Due DL; Sirgo MA
    J Clin Pharmacol; 1990 Jun; 30(6):524-32. PubMed ID: 2355103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
    Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dilevalol and enalapril administered once daily for mild hypertension.
    Rodriguez-Saavedra M; Zannad FM; Guerrero-Sierra J; Sack DW; Renaud H; Guiducci U; Edwards LD
    Am J Cardiol; 1989 Jun; 63(19):50I-53I. PubMed ID: 2543201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol in the treatment of hypertension in elderly and younger patients.
    Abernethy DR; Bartos P; Plachetka JR
    J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of isolated systolic hypertension with labetalol in the elderly.
    Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
    Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension.
    White WB; Aydelotte ME
    Am J Med Sci; 1988 Sep; 296(3):187-91. PubMed ID: 2845781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol blunts morning pressor surge in systolic hypertension.
    DeQuattro V; Lee DD; Allen J; Sirgo M; Plachetka J
    Hypertension; 1988 Feb; 11(2 Pt 2):I198-201. PubMed ID: 3278976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
    Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP; Durier P; Bussiere JL; Gayet JL
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.